Margetuximab
RxNorm 2473851
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2473851 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: margetuximab.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Margetuximab
(Atom ID: 12531779)
PTPrescribable
Designated preferred name (PT):
Margetuximab
(Atom ID: 12665291)
FNPrescribable
Full form of descriptor (FN):
Margetuximab (substance)
(Atom ID: 12665292)
PTPrescribable
Designated preferred name (PT):
Margetuximab-containing product
(Atom ID: 12665295)
FNPrescribable
Full form of descriptor (FN):
Product containing margetuximab (medicinal product)
(Atom ID: 12665565)
Patient Education
Margetuximab-cmkb Injection
Margetuximab-cmkb is used along with chemotherapy to treat a certain type of breast cancer (HER-2 positive) that has spread to other parts of the body after treatment with at least two other chemotherapy medications. Margetuximab-cmkb is in a class of medications called monoclonal antibodies. It works by stopping the growth of cancer cells.
[Learn More]
* Please review the disclaimer below.